{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:29:27Z","timestamp":1786580967485,"version":"build-2736575974"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":72,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-54715-6","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:36:57Z","timestamp":1780418217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dual-targeted glutathione-glutamate functionalized Bismuth-Niosomes hybrid nanosystem for co-delivery of doxorubicin and Pi3K inhibitor into U87 glioblastoma cells"],"prefix":"10.1038","volume":"16","author":[{"given":"Zahra","family":"Bigdelou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Gharbavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghasem","family":"Bagherpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Rezaeejam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behrooz","family":"Johari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,2]]},"reference":[{"key":"54715_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105780","volume":"171","author":"W Wu","year":"2021","unstructured":"Wu, W. et al. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacol. Res. 171, 105780 (2021).","journal-title":"Pharmacol. Res."},{"key":"54715_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.116113","volume":"171","author":"C Zhao","year":"2024","unstructured":"Zhao, C. et al. Lipid-based nanoparticles to address the limitations of GBM therapy by overcoming the blood-brain barrier, targeting glioblastoma stem cells, and counteracting the immunosuppressive tumor microenvironment. Biomed. Pharmacother. 171, 116113 (2024).","journal-title":"Biomed. Pharmacother."},{"key":"54715_CR3","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s13346-019-00679-2","volume":"10","author":"L Jena","year":"2020","unstructured":"Jena, L., McErlean, E. & McCarthy, H. Delivery across the blood-brain barrier: nanomedicine for glioblastoma multiforme. Drug delivery translational Res. 10, 304\u2013318 (2020).","journal-title":"Drug delivery translational Res."},{"key":"54715_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17071211","author":"RN Liu","year":"2025","unstructured":"Liu, R. N. et al. Tumor Treating Fields and combination therapy in management of brain oncology. Cancers https:\/\/doi.org\/10.3390\/cancers17071211 (2025).","journal-title":"Cancers"},{"key":"54715_CR5","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/s41423-024-01226-x","volume":"21","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Zhou, F., Ali, H., Lathia, J. D. & Chen, P. Immunotherapy for glioblastoma: current state, challenges, and future perspectives. Cell. Mol. Immunol. 21, 1354\u20131375 (2024).","journal-title":"Cell. Mol. Immunol."},{"key":"54715_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cells12040659","author":"M Kciuk","year":"2023","unstructured":"Kciuk, M. et al. Doxorubicin-An agent with multiple mechanisms of anticancer activity. Cells https:\/\/doi.org\/10.3390\/cells12040659 (2023).","journal-title":"Cells"},{"key":"54715_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111708","volume":"139","author":"PS Rawat","year":"2021","unstructured":"Rawat, P. S., Jaiswal, A., Khurana, A., Bhatti, J. S. & Navik, U. Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management. Biomed. Pharmacother. 139, 111708 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"54715_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1441460","volume":"14","author":"WH Bae","year":"2024","unstructured":"Bae, W. H., Maraka, S. & Daher, A. Challenges and advances in glioblastoma targeted therapy: The promise of drug repurposing and biomarker exploration. Front. Oncol. 14, 1441460 (2024).","journal-title":"Front. Oncol."},{"key":"54715_CR9","doi-asserted-by":"publisher","DOI":"10.1002\/ddr.22261","volume":"85","author":"S Satish","year":"2024","unstructured":"Satish, S., Athavale, M. & Kharkar, P. S. Targeted therapies for glioblastoma multiforme (GBM): State-of-the-art and future prospects. Drug Dev. Res. 85, e22261 (2024).","journal-title":"Drug Dev. Res."},{"key":"54715_CR10","doi-asserted-by":"publisher","first-page":"38022","DOI":"10.18632\/oncotarget.16723","volume":"8","author":"R Bayat Mokhtari","year":"2017","unstructured":"Bayat Mokhtari, R. et al. Combination therapy in combating cancer. Oncotarget 8, 38022\u201338043 (2017).","journal-title":"Oncotarget"},{"key":"54715_CR11","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1007\/s12672-024-01195-7","volume":"15","author":"DC Joshi","year":"2024","unstructured":"Joshi, D. C. et al. Novel therapeutic agents in clinical trials: emerging approaches in cancer therapy. Discover Oncol. 15, 342 (2024).","journal-title":"Discover Oncol."},{"key":"54715_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.572904","author":"Q Xia","year":"2020","unstructured":"Xia, Q. et al. Therapeutic potential of autophagy in glioblastoma treatment with Phosphoinositide 3-Kinase\/Protein Kinase B\/Mammalian Target of Rapamycin Signaling Pathway Inhibitors. Front. Oncol. https:\/\/doi.org\/10.3389\/fonc.2020.572904 (2020).","journal-title":"Front. Oncol."},{"key":"54715_CR13","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1038\/sj.cdd.4401677","volume":"12","author":"J Bar","year":"2005","unstructured":"Bar, J. et al. The PI3K inhibitor LY294002 prevents p53 induction by DNA damage and attenuates chemotherapy-induced apoptosis. Cell Death Differ. 12, 1578\u20131587 (2005).","journal-title":"Cell Death Differ."},{"key":"54715_CR14","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bbapap.2007.09.008","volume":"1784","author":"BH Jiang","year":"2008","unstructured":"Jiang, B. H. & Liu, L. Z. PI3K\/PTEN signaling in tumorigenesis and angiogenesis. Biochimica et Biophysica Acta (BBA) 1784, 150\u2013158 (2008).","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"key":"54715_CR15","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1158\/0008-5472.CAN-12-1365","volume":"73","author":"M Rahmani","year":"2013","unstructured":"Rahmani, M. et al. Dual inhibition of Bcl-2 and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in human myeloid leukemia cells through a GSK3- and Bim-dependent mechanism. Cancer Res. 73, 1340\u20131351 (2013).","journal-title":"Cancer Res."},{"key":"54715_CR16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052898","volume":"7","author":"D Marklein","year":"2012","unstructured":"Marklein, D. et al. PI3K inhibition enhances doxorubicin-induced apoptosis in sarcoma cells. PLoS One 7, e52898 (2012).","journal-title":"PLoS One"},{"key":"54715_CR17","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1124\/mol.115.099143","volume":"88","author":"DE Durrant","year":"2015","unstructured":"Durrant, D. E. et al. Targeted inhibition of phosphoinositide 3-kinase\/mammalian target of rapamycin sensitizes pancreatic cancer cells to doxorubicin without exacerbating cardiac toxicity. Mol. Pharmacol. 88, 512\u2013523 (2015).","journal-title":"Mol. Pharmacol."},{"key":"54715_CR18","doi-asserted-by":"crossref","unstructured":"Lange, F., H\u00f6rnschemeyer, M. F. & Kirschstein, T. Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy. Cells 10. (2021).","DOI":"10.3390\/cells10051226"},{"key":"54715_CR19","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1007\/s00044-024-03225-z","volume":"33","author":"X Guan","year":"2024","unstructured":"Guan, X. Glutathione transporter as a target for brain drug delivery. Med. Chem. Res. 33, 1281\u20131291 (2024).","journal-title":"Med. Chem. Res."},{"key":"54715_CR20","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s11064-020-03030-1","volume":"45","author":"D Dwivedi","year":"2020","unstructured":"Dwivedi, D., Megha, K., Mishra, R. & Mandal, P. K. Glutathione in Brain: Overview of Its Conformations, Functions, Biochemical Characteristics, Quantitation and Potential Therapeutic Role in Brain Disorders. Neurochem. Res. 45, 1461\u20131480 (2020).","journal-title":"Neurochem. Res."},{"key":"54715_CR21","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1007\/s43440-024-00644-y","volume":"76","author":"M Biega\u0144ski","year":"2024","unstructured":"Biega\u0144ski, M. & Szeliga, M. Disrupted glutamate homeostasis as a target for glioma therapy. Pharmacol. Rep. 76, 1305\u20131317 (2024).","journal-title":"Pharmacol. Rep."},{"key":"54715_CR22","first-page":"6847971","volume":"2018","author":"M Gharbavi","year":"2018","unstructured":"Gharbavi, M., Amani, J., Kheiri-Manjili, H., Danafar, H. & Sharafi, A. Niosome: A Promising Nanocarrier for Natural Drug Delivery through Blood-Brain Barrier. Adv. Pharmacol. Pharmaceut. Sci. 2018, 6847971 (2018).","journal-title":"Adv. Pharmacol. Pharmaceut. Sci."},{"key":"54715_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120758","volume":"604","author":"MT Luiz","year":"2021","unstructured":"Luiz, M. T. et al. Highlights in targeted nanoparticles as a delivery strategy for glioma treatment. Int. J. Pharm. 604, 120758 (2021).","journal-title":"Int. J. Pharm."},{"key":"54715_CR24","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1049\/nbt2.12134","volume":"17","author":"D Shahbazi-Gahrouei","year":"2023","unstructured":"Shahbazi-Gahrouei, D., Choghazardi, Y., Kazemzadeh, A., Naseri, P. & Shahbazi-Gahrouei, S. A review of bismuth-based nanoparticles and their applications in radiosensitising and dose enhancement for cancer radiation therapy. IET Nanobiotechnol. 17, 302\u2013311 (2023).","journal-title":"IET Nanobiotechnol."},{"key":"54715_CR25","doi-asserted-by":"publisher","DOI":"10.2147\/ijn.s228919","author":"NNT Sisin","year":"2019","unstructured":"Sisin, N. N. T. & Mat Nawi, N. Radiosensitization effects by bismuth oxide nanoparticles in combination with cisplatin for high dose rate brachytherapy. Int. J. Nanomedicine. https:\/\/doi.org\/10.2147\/ijn.s228919 (2019).","journal-title":"Int. J. Nanomedicine."},{"key":"54715_CR26","first-page":"55","volume":"5","author":"Z Alyani Nezhad","year":"2020","unstructured":"Alyani Nezhad, Z. et al. Investigation of the dose enhancement effect of spherical bismuth oxide nanoparticles in external beam radiotherapy. Nanomed. Res. J. 5, 55\u201362 (2020).","journal-title":"Nanomed. Res. J."},{"key":"54715_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05074-1","volume":"15","author":"S Heidari","year":"2025","unstructured":"Heidari, S., Gharbavi, M., Ghorbani, R., Rezaeejam, H. & Johari, B. Combined treatment using bismuth sulfide nanoparticles loaded with NANOG decoy oligodeoxynucleotides under X-ray radiation for breast cancer cells. Sci. Rep. 15, 23131 (2025).","journal-title":"Sci. Rep."},{"key":"54715_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.32604\/or.2023.043576","volume":"32","author":"B Johari","year":"2023","unstructured":"Johari, B. et al. Combinational therapy with Myc decoy oligodeoxynucleotides encapsulated in nanocarrier and X-irradiation on breast cancer cells. Oncol. Res. 32, 309 (2023).","journal-title":"Oncol. Res."},{"key":"54715_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e34096","author":"B Johari","year":"2024","unstructured":"Johari, B. et al. Suppress the cell growth of cancer stem-like cells (NTERA-2) using Sox2-Oct4 decoy oligodeoxynucleotide\u2013 encapsulated niosomes-zinc hybrid nanocarriers under X-irradiation. Heliyon https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34096 (2024).","journal-title":"Heliyon"},{"key":"54715_CR30","doi-asserted-by":"publisher","first-page":"5242","DOI":"10.1021\/acs.langmuir.1c00182","volume":"37","author":"R Karunanithy","year":"2021","unstructured":"Karunanithy, R., Holland, T. & Sivakumar, P. Influence of glutaraldehyde\u2019s molecular transformations on spectroscopic investigations of its conjugation with amine-modified Fe3O4 microparticles in the reaction medium. Langmuir 37, 5242\u20135251 (2021).","journal-title":"Langmuir"},{"key":"54715_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s10876-025-02889-w","volume":"36","author":"HM Saleh","year":"2025","unstructured":"Saleh, H. M., Albukhaty, S., Al-Karagoly, H., Sulaiman, G. M. & Gharbavi, M. Optimized alginate-glycerol nano-hydrogel composites for enhanced Methylene Blue removal: Kinetic and isotherm analysis. J. Cluster Sci. 36, 162 (2025).","journal-title":"J. Cluster Sci."},{"key":"54715_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/aoc.70279","volume":"39","author":"H Rashidzadeh","year":"2025","unstructured":"Rashidzadeh, H. et al. Co-encapsulated niosomes with Metformin and Silver nanoparticles as potential anticancer tool for the combined therapy on lung cancer cells. Appl. Organomet. Chem. 39, e70279 (2025).","journal-title":"Appl. Organomet. Chem."},{"key":"54715_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/slct.202500588","volume":"10","author":"R Ghorbani","year":"2025","unstructured":"Ghorbani, R. et al. Investigating the antitumor efficacy of NL2 peptide-conjugated silica nanoparticles loaded with NANOG decoy oligodeoxynucleotides for targeted delivery into breast cancer cells. ChemistrySelect 10, e00588 (2025).","journal-title":"ChemistrySelect"},{"key":"54715_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s10924-025-03591-8","author":"B Keshavarz","year":"2025","unstructured":"Keshavarz, B., Gharbavi, M., Bagherpour, G., Rezaeejam, H. & Johari, B. Green-synthesized Silver nanoparticles coated with Alginate and conjugated to Docetaxel drug: Combination therapy under X-irradiation on LNCaP prostate cancer cells. J. Polym. Environ. https:\/\/doi.org\/10.1007\/s10924-025-03591-8 (2025).","journal-title":"J. Polym. Environ."},{"key":"54715_CR35","unstructured":"Zhao, P., X. Hou, J. Yan, S. Du, Y. Xue, W. Li, G. Xiang, and Y. Dong."},{"key":"54715_CR36","doi-asserted-by":"crossref","unstructured":"Jafari, B. et al. Mitigated oxidative stress and cognitive impairments in transient global ischemia using niosomal selegiline-nbp delivery. Behav. Neurol. 2022, 4825472. (2022).","DOI":"10.1155\/2022\/4825472"},{"key":"54715_CR37","doi-asserted-by":"publisher","first-page":"106791","DOI":"10.1016\/j.jddst.2025.106791","volume":"107","author":"H Soroushnasab","year":"2025","unstructured":"Soroushnasab, H. et al. Methotrexate-conjugated silver nanoparticles enhance chemoradiotherapy effects on U87 human glioblastoma multiforme cells: As a radiosensitizer agent to improve X-irradiation efficacy. J. Drug Deliv. Sci. Technol. 107, 106791 (2025).","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"54715_CR38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.2217\/nnm-2021-0334","volume":"17","author":"N Mousazadeh","year":"2022","unstructured":"Mousazadeh, N. et al. Anticancer evaluation of methotrexate and curcumin-coencapsulated niosomes against colorectal cancer cell lines. Nanomedicine 17, 201\u2013217 (2022).","journal-title":"Nanomedicine"},{"key":"54715_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/aoc.6926","volume":"37","author":"M Gharbavi","year":"2023","unstructured":"Gharbavi, M., Johari, B., Ghorbani, R., Madanchi, H. & Sharafi, A. Green synthesis of Zn nanoparticles and in situ hybridized with BSA nanoparticles for Baicalein targeted delivery mediated with glutamate receptors to U87-MG cancer cell lines. Appl. Organomet. Chem. 37, e6926 (2023).","journal-title":"Appl. Organomet. Chem."},{"key":"54715_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032914","author":"IP S\u00e6b\u00f8","year":"2023","unstructured":"S\u00e6b\u00f8, I. P., Bj\u00f8r\u00e5s, M., Franzyk, H., Helgesen, E. & Booth, J. A. Optimization of the hemolysis assay for the assessment of cytotoxicity. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms24032914 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"54715_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.124285","volume":"659","author":"N Asadi","year":"2024","unstructured":"Asadi, N., Gharbavi, M., Rezaeejam, H., Farajollahi, A. & Johari, B. Zinc nanoparticles coated with doxorubicin-conjugated alginate as a radiation sensitizer in triple-negative breast cancer cells. Int. J. Pharm. 659, 124285 (2024).","journal-title":"Int. J. Pharm."},{"key":"54715_CR42","doi-asserted-by":"publisher","first-page":"5429","DOI":"10.1002\/jcp.29431","volume":"235","author":"M Rahmati","year":"2020","unstructured":"Rahmati, M., Johari, B., Kadivar, M., Rismani, E. & Mortazavi, Y. Suppressing the metastatic properties of the breast cancer cells using STAT3 decoy oligodeoxynucleotides: a promising approach for eradication of cancer cells by differentiation therapy. J. Cell. Physiol. 235, 5429\u20135444 (2020).","journal-title":"J. Cell. Physiol."},{"key":"54715_CR43","doi-asserted-by":"publisher","DOI":"10.32604\/or.2023.044741","volume":"32","author":"R Ghorbani","year":"2023","unstructured":"Ghorbani, R. et al. Targeted anti-tumor synergistic effects of Myc decoy oligodeoxynucleotides-loaded selenium nanostructure combined with chemoradiotherapy on LNCaP prostate cancer cells. Oncol. Res. 32, 101 (2023).","journal-title":"Oncol. Res."},{"key":"54715_CR44","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1002\/cbin.11456","volume":"44","author":"B Johari","year":"2020","unstructured":"Johari, B. et al. Evaluation of STAT3 decoy oligodeoxynucleotides\u2019 synergistic effects on radiation and\/or chemotherapy in metastatic breast cancer cell line. Cell. Biol. Int. 44, 2499\u20132511 (2020).","journal-title":"Cell. Biol. Int."},{"key":"54715_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17010146","author":"D Sipos","year":"2025","unstructured":"Sipos, D. et al. Glioblastoma: Clinical presentation, multidisciplinary management, and long-term outcomes. Cancers https:\/\/doi.org\/10.3390\/cancers17010146 (2025).","journal-title":"Cancers"},{"key":"54715_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/aoc.5251","volume":"34","author":"S Azizi","year":"2020","unstructured":"Azizi, S., Nosrati, H., Sharafi, A. & Danafar, H. Preparation of Bismuth sulfide nanoparticles as targeted biocompatible nano-radiosensitizer and carrier of Methotrexate. Appl. Organomet. Chem. 34, e5251 (2020).","journal-title":"Appl. Organomet. Chem."},{"key":"54715_CR47","doi-asserted-by":"publisher","DOI":"10.1080\/02652048.2025.2507638","author":"H Qing","year":"2025","unstructured":"Qing, H. et al. The pH-controlled release properties of chitosan\u2013gold nanoparticles encapsulated nobiletin to induce apoptosis through PI3K\/AKT\/mTOR signalling pathway on gastric cancer cell lines. J. Microencapsul. https:\/\/doi.org\/10.1080\/02652048.2025.2507638 (2025).","journal-title":"J. Microencapsul."},{"key":"54715_CR48","doi-asserted-by":"publisher","first-page":"137636","DOI":"10.1016\/j.molstruc.2024.137636","volume":"1304","author":"D Jovi\u0107","year":"2024","unstructured":"Jovi\u0107, D., Jovi\u0107, B. & Djordjevi\u0107, A. A peek under the peak: Spectroscopic investigation of potential charge transfer and hydrogen-bonded complexes of doxorubicin with fullerenol nanoparticles. J. Mol. Struct. 1304, 137636 (2024).","journal-title":"J. Mol. Struct."},{"key":"54715_CR49","doi-asserted-by":"publisher","first-page":"770","DOI":"10.3390\/pharmaceutics13060770","volume":"13","author":"PM Perrigue","year":"2021","unstructured":"Perrigue, P. M., Murray, R. A., Mielcarek, A., Henschke, A. & Moya, S. E. Degradation of drug delivery nanocarriers and payload release: A review of physical methods for tracing nanocarrier biological fate. Pharmaceutics 13, 770 (2021).","journal-title":"Pharmaceutics"},{"key":"54715_CR50","volume-title":"Mechanism and Development of Peptide-Based Inhibitors to Human Islet Amyloid Polypeptide (hIAPP) Self-Assembly","author":"J Vedad","year":"2018","unstructured":"Vedad, J. Mechanism and Development of Peptide-Based Inhibitors to Human Islet Amyloid Polypeptide (hIAPP) Self-Assembly (City University of New York, 2018)."},{"key":"54715_CR51","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1021\/acsomega.2c06218","volume":"8","author":"R Kaushik","year":"2022","unstructured":"Kaushik, R., Nehra, N., Novakova, V. & Zimcik, P. Near-infrared probes for biothiols (cysteine, homocysteine, and glutathione): A comprehensive review. Acs Omega. 8, 98\u2013126 (2022).","journal-title":"Acs Omega"},{"key":"54715_CR52","doi-asserted-by":"publisher","first-page":"522","DOI":"10.3390\/bios14110522","volume":"14","author":"V Moha\u010dek-Gro\u0161ev","year":"2024","unstructured":"Moha\u010dek-Gro\u0161ev, V. et al. Binding of glutamic acid to silver and gold nanoparticles investigated by surface-enhanced Raman spectroscopy. Biosensors 14, 522 (2024).","journal-title":"Biosensors"},{"key":"54715_CR53","doi-asserted-by":"publisher","first-page":"17258","DOI":"10.1021\/acs.inorgchem.1c02621","volume":"60","author":"D Leng","year":"2021","unstructured":"Leng, D. et al. Plasmonic bismuth nanoparticles: Thiolate pyrolysis synthesis, size-dependent LSPR property, and their oxidation behavior. Inorg. Chem. 60, 17258\u201317267 (2021).","journal-title":"Inorg. Chem."},{"key":"54715_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.optmat.2023.114433","volume":"145","author":"D Ma","year":"2023","unstructured":"Ma, D., Pan, S., Tan, M., He, G. & Zhao, J. Shape-controlled synthesis of varied bismuth nanostructures and their size-dependent photocatalytic removal of organic dyes under visible light irradiation. Opt. Mater. 145, 114433 (2023).","journal-title":"Opt. Mater."},{"key":"54715_CR55","unstructured":"Fergusson, A., Zhang, R. & Riffle, J. and R. Davis. (2023)."},{"key":"54715_CR56","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3390\/cells12030392","volume":"12","author":"G Greco","year":"2023","unstructured":"Greco, G. et al. Light-enhanced cytotoxicity of doxorubicin by photoactivation. Cells 12, 392 (2023).","journal-title":"Cells"},{"key":"54715_CR57","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/elps.201600354","volume":"38","author":"J La\u010dn\u00e1","year":"2017","unstructured":"La\u010dn\u00e1, J., Foret, F. & Kub\u00e1\u0148, P. Capillary electrophoresis in the analysis of biologically important thiols. Electrophoresis 38, 203\u2013222 (2017).","journal-title":"Electrophoresis"},{"key":"54715_CR58","doi-asserted-by":"publisher","first-page":"3321","DOI":"10.1021\/acschemneuro.4c00247","volume":"15","author":"C Geoffroy","year":"2024","unstructured":"Geoffroy, C. et al. Reversible control of native GluN2B-containing NMDA receptors with visible light. ACS Chem. Neurosci. 15, 3321\u20133343 (2024).","journal-title":"ACS Chem. Neurosci."},{"issue":"7","key":"54715_CR59","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11095-020-02865-1","volume":"37","author":"RGR Pinheiro","year":"2020","unstructured":"Pinheiro, R. G. R. et al. RVG29-functionalized lipid nanoparticles for quercetin brain delivery and Alzheimer\u2019s Disease. Pharm. Res. 37139. (2020).","journal-title":"Pharm. Res."},{"key":"54715_CR60","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s10765-025-03557-x","volume":"46","author":"KA AlMuhaysh","year":"2025","unstructured":"AlMuhaysh, K. A., Sergis, A. & Hardalupas, Y. Effects of pH and Nanoparticle Concentration on Al2O3\u2013H2O Nanofluid Stability. Int. J. Thermophys. 46, 82 (2025).","journal-title":"Int. J. Thermophys."},{"key":"54715_CR61","doi-asserted-by":"publisher","DOI":"10.1039\/d4tb01114g","author":"S Bagherpour","year":"2024","unstructured":"Bagherpour, S. & P\u00e9rez-Garc\u00eda, L. Recent advances on nanomaterial-based glutathione sensors. J. Mater. Chem. B https:\/\/doi.org\/10.1039\/d4tb01114g (2024).","journal-title":"J. Mater. Chem. B"},{"key":"54715_CR62","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1039\/D4TB00312H","volume":"12","author":"T Scattolin","year":"2024","unstructured":"Scattolin, T. et al. Synergistic applications of cyclodextrin-based systems and metal\u2013organic frameworks in transdermal drug delivery for skin cancer therapy. J. Mater. Chem. B 12, 3807\u20133839 (2024).","journal-title":"J. Mater. Chem. B"},{"key":"54715_CR63","volume-title":"Mesoporous silicates: Materials science and biological applications","author":"RA Roggers","year":"2012","unstructured":"Roggers, R. A. Mesoporous silicates: Materials science and biological applications (Iowa State University, 2012)."},{"key":"54715_CR64","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12034-008-0016-2","volume":"31","author":"M Nidhin","year":"2008","unstructured":"Nidhin, M., Indumathy, R., Sreeram, K. J. & Nair, B. U. Synthesis of iron oxide nanoparticles of narrow size distribution on polysaccharide templates. Bull. Mater. Sci. 31, 93\u201396 (2008).","journal-title":"Bull. Mater. Sci."},{"key":"54715_CR65","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/S0163-7827(03)00033-X","volume":"42","author":"SM Moghimi","year":"2003","unstructured":"Moghimi, S. M. & Szebeni, J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 42, 463\u2013478 (2003).","journal-title":"Prog. Lipid Res."},{"key":"54715_CR66","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/pharmaceutics15020443","volume":"15","author":"T Ili\u0107","year":"2023","unstructured":"Ili\u0107, T. et al. Parenteral lipid-based nanoparticles for CNS disorders: integrating various facets of preclinical evaluation towards more effective clinical translation. Pharmaceutics 15, 443 (2023).","journal-title":"Pharmaceutics"},{"key":"54715_CR67","unstructured":"Sopyan, I. & Gozali, D. A Review: A Novel of Efforts to Enhance Liposome Stability as Drug Delivery Approach.\u00a0Syst. Rev. Pharm.\u00a011. (2020)."},{"key":"54715_CR68","doi-asserted-by":"crossref","unstructured":"Singh, R. & Singh, S. Nanomaterials in Human Disease Diagnosis. (2019).","DOI":"10.1039\/9781782628217-00249"},{"key":"54715_CR69","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1021\/acs.langmuir.2c02657","volume":"39","author":"ZJ Jakubek","year":"2023","unstructured":"Jakubek, Z. J., Chen, S., Zaifman, J., Tam, Y. Y. C. & Zou, S. Lipid nanoparticle and liposome reference materials: Assessment of size homogeneity and long-term\u2009\u2013\u200970\u00a0C and 4\u00a0C storage stability. Langmuir 39, 2509\u20132519 (2023).","journal-title":"Langmuir"},{"key":"54715_CR70","doi-asserted-by":"crossref","unstructured":"Makoni, P. A., Wa, K., Kasongo & Walker, R. B. In: Pharmaceutics. 11, 397. (2019).","DOI":"10.3390\/pharmaceutics11080397"},{"key":"54715_CR71","doi-asserted-by":"publisher","first-page":"6492","DOI":"10.1021\/acs.molpharmaceut.3c00956","volume":"20","author":"AG Reinhart","year":"2023","unstructured":"Reinhart, A. G. et al. Investigations into mRNA Lipid Nanoparticles Shelf-Life Stability under Nonfrozen Conditions. Mol. Pharm. 20, 6492\u20136503 (2023).","journal-title":"Mol. Pharm."},{"key":"54715_CR72","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.colsurfa.2015.04.017","volume":"480","author":"S Rohiwal","year":"2015","unstructured":"Rohiwal, S., Tiwari, A., Verma, G. & Pawar, S. Preparation and evaluation of bovine serum albumin nanoparticles for ex vivo colloidal stability in biological media. Colloids Surf., A. 480, 28\u201337 (2015).","journal-title":"Colloids Surf., A"},{"key":"54715_CR73","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1039\/C9CS00283A","volume":"49","author":"MA Shahbazi","year":"2020","unstructured":"Shahbazi, M. A. et al. The versatile biomedical applications of bismuth-based nanoparticles and composites: therapeutic, diagnostic, biosensing, and regenerative properties. Chem. Soc. Rev. 49, 1253\u20131321 (2020).","journal-title":"Chem. Soc. Rev."},{"key":"54715_CR74","doi-asserted-by":"publisher","first-page":"1700575","DOI":"10.1002\/adhm.201700575","volume":"7","author":"Q Dai","year":"2018","unstructured":"Dai, Q. et al. Particle targeting in complex biological media. Adv. Healthc. Mater. 7, 1700575 (2018).","journal-title":"Adv. Healthc. Mater."},{"key":"54715_CR75","first-page":"3554","volume":"9","author":"AJ Jasim","year":"2024","unstructured":"Jasim, A. J. et al. Liposome nanocarriers based on \u03b3 Oryzanol: Preparation, characterization, and in vivo assessment of toxicity and antioxidant activity. ACS Omega 9, 3554\u20133564 (2024).","journal-title":"ACS Omega"},{"key":"54715_CR76","doi-asserted-by":"publisher","first-page":"2203678","DOI":"10.1002\/smll.202203678","volume":"18","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Micro-nanocarriers based drug delivery technology for blood\u2010brain barrier crossing and brain tumor targeting therapy. Small 18, 2203678 (2022).","journal-title":"Small"},{"key":"54715_CR77","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2025.5789","author":"JX Si","year":"2025","unstructured":"Si, J. X., Liu, Z. C., Gu, F., Jin, X. & Ma, Y. Y. Nanoparticle\u2013based delivery systems for targeted therapy in brain tumors: Progress, challenges and perspectives (Review). Int. J. Oncol. https:\/\/doi.org\/10.3892\/ijo.2025.5789 (2025).","journal-title":"Int. J. Oncol."},{"key":"54715_CR78","doi-asserted-by":"publisher","first-page":"311","DOI":"10.7150\/ntno.38954","volume":"3","author":"C Liu","year":"2019","unstructured":"Liu, C. et al. Enhanced blood-brain-barrier penetrability and tumor-targeting efficiency by peptide-functionalized poly(amidoamine) dendrimer for the therapy of gliomas. Nanotheranostics 3, 311\u2013330 (2019).","journal-title":"Nanotheranostics"},{"key":"54715_CR79","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.7150\/thno.18985","volume":"7","author":"Q Feng","year":"2017","unstructured":"Feng, Q. et al. Self-assembly of gold nanoparticles shows microenvironment-mediated dynamic switching and enhanced brain tumor targeting. Theranostics 7, 1875\u20131889 (2017).","journal-title":"Theranostics"},{"key":"54715_CR80","doi-asserted-by":"publisher","first-page":"1802417","DOI":"10.1002\/smll.201802417","volume":"14","author":"SY Qin","year":"2018","unstructured":"Qin, S. Y., Zhang, A. Q. & Zhang, X. Z. Recent advances in targeted tumor chemotherapy based on smart nanomedicines. Small 14, 1802417 (2018).","journal-title":"Small"},{"key":"54715_CR81","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1080\/17425247.2023.2292678","volume":"20","author":"Z Chen","year":"2023","unstructured":"Chen, Z., Wang, X., Zhao, N., Chen, H. & Guo, G. Advancements in pH-responsive nanocarriers: enhancing drug delivery for tumor therapy. Expert Opin. Drug Deliv. 20, 1623\u20131642 (2023).","journal-title":"Expert Opin. Drug Deliv."},{"key":"54715_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33696\/Pharmacol.7.060","volume":"7","author":"G Debnath","year":"2025","unstructured":"Debnath, G., Vasu, B., Gorla, R. S. R., B\u00e9g, O. A. & B\u00e9g, T. A. Integrating mathematical models in clinical oncology: Enhancing therapeutic strategies. Arch. Pharmacol. Ther. 7, 1\u201327 (2025).","journal-title":"Arch. Pharmacol. Ther."},{"key":"54715_CR83","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/toxsci\/kfr149","volume":"123","author":"J Choi","year":"2011","unstructured":"Choi, J., Reipa, V., Hitchins, V. M., Goering, P. L. & Malinauskas, R. A. Physicochemical characterization and in vitro hemolysis evaluation of silver nanoparticles. Toxicol. Sci. 123, 133\u2013143 (2011).","journal-title":"Toxicol. Sci."},{"key":"54715_CR84","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.jen.2012.11.002","volume":"40","author":"H Dietrich","year":"2014","unstructured":"Dietrich, H. One poke or two: can intravenous catheters provide an acceptable blood sample? A data set presentation, review of previous data sets, and discussion. J. Emerg. Nurs. 40, 575\u2013578 (2014).","journal-title":"J. Emerg. Nurs."},{"key":"54715_CR85","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.jen.2015.10.012","volume":"42","author":"MP Phelan","year":"2016","unstructured":"Phelan, M. P., Reineks, E. Z. & Kovach, A. C. Intravenous catheters and blood samples. J. Emerg. Nurs. 42, 102\u2013103 (2016).","journal-title":"J. Emerg. Nurs."},{"key":"54715_CR86","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/sj.bjp.0705861","volume":"142","author":"VJ Collett","year":"2004","unstructured":"Collett, V. J. & Collingridge, G. L. Interactions between NMDA receptors and mGlu5 receptors expressed in HEK293 cells. Br. J. Pharmacol. 142, 991\u20131001 (2004).","journal-title":"Br. J. Pharmacol."},{"key":"54715_CR87","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1477-3155-12-5","volume":"12","author":"L Shang","year":"2014","unstructured":"Shang, L., Nienhaus, K. & Nienhaus, G. U. Engineered nanoparticles interacting with cells: size matters. J. Nanobiotechnol. 12, 5 (2014).","journal-title":"J. Nanobiotechnol."},{"key":"54715_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/srep02534","volume":"3","author":"H Gao","year":"2013","unstructured":"Gao, H. et al. Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization. Sci. Rep. 3, 2534 (2013).","journal-title":"Sci. Rep."},{"key":"54715_CR89","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102837","author":"L Kou","year":"2020","unstructured":"Kou, L. et al. Transporter-targeted nano-sized vehicles for enhanced and site-specific drug delivery. Cancers https:\/\/doi.org\/10.3390\/cancers12102837 (2020).","journal-title":"Cancers"},{"key":"54715_CR90","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.colsurfb.2016.01.041","volume":"141","author":"L Li","year":"2016","unstructured":"Li, L. et al. Large amino acid transporter 1 mediated glutamate modified docetaxel-loaded liposomes for glioma targeting. Colloids Surf. B Biointerfaces 141, 260\u2013267 (2016).","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"54715_CR91","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s11671-025-04249-z","volume":"20","author":"ME Moutaoukil","year":"2025","unstructured":"Moutaoukil, M. E. et al. Doxorubicin and NFL-TBS.40\u201363 peptide loaded gold nanoparticles as a multimodal therapy of glioblastoma. Discov Nano. 20, 72 (2025).","journal-title":"Discov Nano"},{"key":"54715_CR92","doi-asserted-by":"publisher","first-page":"14283","DOI":"10.1073\/pnas.1614898113","volume":"113","author":"J Han","year":"2016","unstructured":"Han, J. et al. Rapid emergence and mechanisms of resistance by U87 glioblastoma cells to doxorubicin in an in vitro tumor microfluidic ecology. Proceedings of the National Academy of Sciences 113, 14283\u201314288 (2016).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"54715_CR93","doi-asserted-by":"publisher","first-page":"11292","DOI":"10.1038\/s41598-020-68017-y","volume":"10","author":"M Norouzi","year":"2020","unstructured":"Norouzi, M. et al. Doxorubicin-loaded iron oxide nanoparticles for glioblastoma therapy: a combinational approach for enhanced delivery of nanoparticles. Sci. Rep. 10, 11292 (2020).","journal-title":"Sci. Rep."},{"key":"54715_CR94","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.brainres.2010.09.097","volume":"1366","author":"L Han","year":"2010","unstructured":"Han, L. et al. Inactivation of PI3K\/AKT signaling inhibits glioma cell growth through modulation of \u03b2-catenin-mediated transcription. Brain Res. 1366, 9\u201317 (2010).","journal-title":"Brain Res."},{"key":"54715_CR95","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1748-717X-4-43","volume":"4","author":"HF Li","year":"2009","unstructured":"Li, H. F., Kim, J. S. & Waldman, T. Radiation-induced Akt activation modulates radioresistance in human glioblastoma cells. Radiat. Oncol. 4, 43 (2009).","journal-title":"Radiat. Oncol."},{"key":"54715_CR96","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12951-020-00751-x","volume":"19","author":"C He","year":"2021","unstructured":"He, C. et al. LRP1-mediated pH-sensitive polymersomes facilitate combination therapy of glioblastoma in vitro and in vivo. J. Nanobiotechnol. 19, 29 (2021).","journal-title":"J. Nanobiotechnol."},{"key":"54715_CR97","doi-asserted-by":"publisher","first-page":"4336","DOI":"10.1021\/acsnano.9b09858","volume":"14","author":"Y Kang","year":"2020","unstructured":"Kang, Y. et al. Tetramodal imaging and synergistic cancer radio-chemotherapy enabled by multiple component-encapsulated zeolitic imidazolate frameworks. ACS nano. 14, 4336\u20134351 (2020).","journal-title":"ACS nano"},{"key":"54715_CR98","doi-asserted-by":"publisher","first-page":"23047","DOI":"10.1021\/jp306543q","volume":"116","author":"M Hossain","year":"2012","unstructured":"Hossain, M. & Su, M. Nanoparticle location and material-dependent dose enhancement in X-ray radiation therapy. J. Phys. Chem. C. 116, 23047\u201323052 (2012).","journal-title":"J. Phys. Chem. C"},{"key":"54715_CR99","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/jnc.14250","volume":"144","author":"Z Zhu","year":"2018","unstructured":"Zhu, Z. et al. Glutathione reductase mediates drug resistance in glioblastoma cells by regulating redox homeostasis. J. Neurochem. 144, 93\u2013104 (2018).","journal-title":"J. Neurochem"},{"key":"54715_CR100","doi-asserted-by":"crossref","unstructured":"Porkol\u00e1b, G. et al. Combination of Alanine and Glutathione as Targeting Ligands of Nanoparticles Enhances Cargo Delivery into the Cells of the Neurovascular Unit. Pharmaceutics 12. (2020).","DOI":"10.3390\/pharmaceutics12070635"},{"key":"54715_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20071796","author":"L Corsi","year":"2019","unstructured":"Corsi, L., Mescola, A. & Alessandrini, A. Glutamate receptors and Glioblastoma Multiforme: An old route for new perspectives. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20071796 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"54715_CR102","doi-asserted-by":"publisher","first-page":"773","DOI":"10.5603\/RPOR.a2021.0094","volume":"26","author":"A Jamil","year":"2021","unstructured":"Jamil, A. et al. Radiosensitization effects by bismuth oxide nanorods of different sizes in megavoltage external beam radiotherapy. Rep. Pract. Oncol. Radiother. 26, 773\u2013784 (2021).","journal-title":"Rep. Pract. Oncol. Radiother."},{"key":"54715_CR103","first-page":"772","volume":"12","author":"B Heshmatian","year":"2022","unstructured":"Heshmatian, B. et al. Cytotoxic and radiosensitizing effects of folic acid-conjugated gold nanoparticles and doxorubicin on colorectal cancer cells. Adv. Pharm. Bull. 12, 772\u2013779 (2022).","journal-title":"Adv. Pharm. Bull."},{"key":"54715_CR104","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1158\/1078-0432.CCR-05-1084","volume":"12","author":"CM Lee","year":"2006","unstructured":"Lee, C. M. et al. Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines. Clin. Cancer Res. 12, 250\u2013256 (2006).","journal-title":"Clin. Cancer Res."},{"key":"54715_CR105","first-page":"1149","volume":"3","author":"KE Rosenzweig","year":"1997","unstructured":"Rosenzweig, K. E., Youmell, M. B., Palayoor, S. T. & Price, B. D. Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay. Clin. Cancer Res. 3, 1149\u20131156 (1997).","journal-title":"Clin. Cancer Res."},{"key":"54715_CR106","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.3390\/cancers13194985","volume":"13","author":"S Usman","year":"2021","unstructured":"Usman, S. et al. Vimentin Is at the Heart of Epithelial Mesenchymal Transition (EMT) Mediated Metastasis. Cancers 13, 4985 (2021).","journal-title":"Cancers"},{"key":"54715_CR107","doi-asserted-by":"publisher","first-page":"10384","DOI":"10.1038\/ncomms10384","volume":"7","author":"S Choi","year":"2016","unstructured":"Choi, S. et al. Bcl-xL promotes metastasis independent of its anti-apoptotic activity. Nat. Commun. 7, 10384 (2016).","journal-title":"Nat. Commun."},{"key":"54715_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23042193","author":"M Morales-Mart\u00ednez","year":"2022","unstructured":"Morales-Mart\u00ednez, M. & Vega, M. I. Roles and regulation of BCL-xL in hematological malignancies. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23042193 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"54715_CR109","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3892\/or.2013.2520","volume":"30","author":"X Xie","year":"2013","unstructured":"Xie, X., Tang, B., Zhou, J., Gao, Q. & Zhang, P. Inhibition of the PI3K\/Akt pathway increases the chemosensitivity of gastric cancer to vincristine. Oncol. Rep. 30, 773\u2013782 (2013).","journal-title":"Oncol. Rep."},{"key":"54715_CR110","doi-asserted-by":"crossref","unstructured":"Mohamadzadeh, M. & Zarei, M. Anticancer activity and evaluation of apoptotic genes expression of 2-azetidinones containing anthraquinone moiety. Mol. Diversity 25. (2021).","DOI":"10.1007\/s11030-020-10142-x"},{"key":"54715_CR111","doi-asserted-by":"crossref","unstructured":"Montalto, F. I. & De Amicis, F. Cyclin D1 in cancer: a molecular connection for cell cycle control, adhesion and invasion in tumor and stroma.\u00a0Cells\u00a09 (2020).","DOI":"10.3390\/cells9122648"},{"key":"54715_CR112","doi-asserted-by":"publisher","first-page":"35267","DOI":"10.1038\/srep35267","volume":"6","author":"Y Zhao","year":"2016","unstructured":"Zhao, Y. et al. Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance. Sci. Rep. 6, 35267 (2016).","journal-title":"Sci. Rep."},{"key":"54715_CR113","doi-asserted-by":"publisher","first-page":"3967","DOI":"10.1007\/s00018-009-0157-5","volume":"66","author":"S Gopinath","year":"2009","unstructured":"Gopinath, S. et al. Doxorubicin-mediated apoptosis in glioma cells requires NFAT3. Cell. Mol. Life Sci. 66, 3967\u20133978 (2009).","journal-title":"Cell. Mol. Life Sci."},{"key":"54715_CR114","doi-asserted-by":"publisher","first-page":"50476","DOI":"10.18632\/oncotarget.9919","volume":"8","author":"S Chen","year":"2017","unstructured":"Chen, S. et al. Inhibition of PI3K\/Akt\/mTOR signaling in PI3KR2-overexpressing colon cancer stem cells reduces tumor growth due to apoptosis. Oncotarget 8, 50476\u201350488 (2017).","journal-title":"Oncotarget"},{"key":"54715_CR115","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1101\/gad.12.22.3499","volume":"12","author":"JA Diehl","year":"1998","unstructured":"Diehl, J. A., Cheng, M., Roussel, M. F. & Sherr, C. J. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12, 3499\u20133511 (1998).","journal-title":"Genes Dev."},{"key":"54715_CR116","doi-asserted-by":"publisher","first-page":"339","DOI":"10.4161\/cc.2.4.433","volume":"2","author":"J Liang","year":"2003","unstructured":"Liang, J. & Slingerland, J. M. Multiple roles of the PI3K\/PKB (Akt) pathway in cell cycle progression. Cell. Cycle. 2, 339\u2013345 (2003).","journal-title":"Cell. Cycle"},{"key":"54715_CR117","doi-asserted-by":"publisher","first-page":"7842","DOI":"10.1128\/MCB.22.22.7842-7852.2002","volume":"22","author":"M Schmidt","year":"2002","unstructured":"Schmidt, M. et al. Cell cycle inhibition by FoxO forkhead transcription factors involves downregulation of cyclin D. Mol. Cell. Biol. 22, 7842\u20137852 (2002).","journal-title":"Mol. Cell. Biol."},{"key":"54715_CR118","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3389\/fonc.2013.00085","volume":"3","author":"L Vadlakonda","year":"2013","unstructured":"Vadlakonda, L., Pasupuleti, M. & Pallu, R. Role of PI3K-AKT-mTOR and Wnt Signaling Pathways in Transition of G1-S Phase of Cell Cycle in Cancer Cells. Front. Oncol. 3, 85 (2013).","journal-title":"Front. Oncol."},{"key":"54715_CR119","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1038\/oncsis.2014.21","volume":"3","author":"P Daniel","year":"2014","unstructured":"Daniel, P. et al. Selective CREB-dependent cyclin expression mediated by the PI3K and MAPK pathways supports glioma cell proliferation. Oncogenesis 3, e108 (2014).","journal-title":"Oncogenesis"},{"key":"54715_CR120","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12896-025-01027-8","volume":"25","author":"R Ezati","year":"2025","unstructured":"Ezati, R. et al. Anticancer effects of folic acid-functionalized covalent organic framework containing doxorubicin on SW480 colon cancer cells: a promising tool for drug targeted delivery. BMC Biotechnol. 25, 91 (2025).","journal-title":"BMC Biotechnol."},{"key":"54715_CR121","doi-asserted-by":"publisher","first-page":"387","DOI":"10.3892\/ol.2013.1711","volume":"7","author":"L Xu","year":"2014","unstructured":"Xu, L. et al. Enhanced activity of doxorubicin in drug resistant A549 tumor cells by encapsulation of P-glycoprotein inhibitor in PLGA-based nanovectors. Oncol. Lett. 7, 387\u2013392 (2014).","journal-title":"Oncol. Lett."},{"key":"54715_CR122","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3892\/ijo_00000565","volume":"36","author":"T David-Pfeuty","year":"2010","unstructured":"David-Pfeuty, T., Legraverend, M., Ludwig, O. & Grierson, D. S. Targeting the cell cycle and the PI3K pathway: a possible universal strategy to reactivate innate tumor suppressor programmes in cancer cells. Int. J. Oncol. 36, 873\u2013881 (2010).","journal-title":"Int. J. Oncol."},{"key":"54715_CR123","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.virol.2007.09.003","volume":"370","author":"SJ Jeong","year":"2008","unstructured":"Jeong, S. J. et al. PI3K\/AKT inhibition induces caspase-dependent apoptosis in HTLV-1-transformed cells. Virology 370, 264\u2013272 (2008).","journal-title":"Virology"},{"key":"54715_CR124","doi-asserted-by":"publisher","first-page":"5973","DOI":"10.2147\/IJN.S130455","volume":"12","author":"F Du","year":"2017","unstructured":"Du, F. et al. Hyaluronic acid-functionalized bismuth oxide nanoparticles for computed tomography imaging-guided radiotherapy of tumor. Int. J. Nanomed. 12, 5973\u20135992 (2017).","journal-title":"Int. J. Nanomed."},{"key":"54715_CR125","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-36347-7","author":"W Diao","year":"2019","unstructured":"Diao, W. et al. Behaviors of glioblastoma cells in in vitro microenvironments. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-018-36347-7 (2019).","journal-title":"Sci. Rep."},{"key":"54715_CR126","unstructured":"Pude\u0142ek, M. & Ryszawy, D. Doxorubicin-induced mitochondrial and cytoskeletal dynamic rearrangements within glioblastoma multiforme cells \u2013 functional consequences for drug resistant phenotype development. (2019)."},{"key":"54715_CR127","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27196201","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Effect of nanoparticles of DOX and miR-125b on DNA damage repair in glioma U251 cells and underlying mechanisms. Molecules https:\/\/doi.org\/10.3390\/molecules27196201 (2022).","journal-title":"Molecules"},{"key":"54715_CR128","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.11372","author":"E Ho Kim","year":"2016","unstructured":"Ho Kim, E., Sook Song, H., Hoon Yoo, S. & Yoon, M. Tumor treating fields inhibit glioblastoma cell migration, invasion and angiogenesis. Oncotarget https:\/\/doi.org\/10.18632\/oncotarget.11372 (2016).","journal-title":"Oncotarget"},{"key":"54715_CR129","doi-asserted-by":"publisher","first-page":"C153","DOI":"10.1152\/ajpcell.00142.2003","volume":"286","author":"Y Qian","year":"2004","unstructured":"Qian, Y. et al. PI3K induced actin filament remodeling through Akt and p70S6K1: implication of essential role in cell migration. Am. J. Physiol. Cell. Physiol. 286, C153\u2013163 (2004).","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"54715_CR130","first-page":"655","volume":"1813","author":"A Kwiatkowska","year":"2011","unstructured":"Kwiatkowska, A., Kijewska, M., Lipko, M., Hibner, U. & Kaminska, B. Downregulation of Akt and FAK phosphorylation reduces invasion of glioblastoma cells by impairment of MT1-MMP shuttling to lamellipodia and downregulates MMPs expression. Biochimica et Biophysica Acta (BBA). Mol. Cell. Res. 1813, 655\u2013667 (2011).","journal-title":"Mol. Cell. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54715-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54715-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54715-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:03:46Z","timestamp":1786579426000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-54715-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,2]]},"references-count":130,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["54715"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-54715-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,2]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable. U87 human glioblastoma cells (ATCC HTB-14) were purchased from the Pasteur Institute of Iran (Tehran, Iran). The hemocompatibility assay involving human red blood cells was approved by the Ethics Committee of Zanjan University of Medical Sciences, Zanjan, Iran (Ethical Code: IR.ZUMS.BLC.1402.027), and all procedures were performed in accordance with the institutional guidelines and the Declaration of Helsinki. Written informed consent was obtained from the donor before blood collection.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for publication of anonymized data was obtained from the blood donor.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"25167"}}